IP Library Granted Patent US 10,722,436
Granted Patent B2
US 10,722,436 · App. 15/233,451 · Granted Jul 28, 2020

Topical compositions

Inventors: Tiffany Carle (Dallas, TX); Michael Frushour (Addison, TX); David Gan (Southlake, TX); Geetha Kalahasti (Plano, TX); Patricia Jacoby (Dallas, TX)
Assignee: Mary Kay Inc.
A61K8/347A61K8/11A61K8/606A61K8/64A61K8/675A61K8/97A61K8/9706A61Q17/04A61Q19/02A61Q19/08A61Q19/10A61K2800/782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,436
App. No.
15/233,451
Granted
Jul 28, 2020
Kind
B2
Abstract

The present invention relates generally to methods and compositions useful for a topical composition comprising encapsulated resveratrol, oligopeptide-1, niacinamide, Opuntia ficus - indica extract, Prunus mume extract, algae extract, malachite extract, adenosine, and/or Opuntia tuna fruit extract.

Claims (20)

1. A method of reducing oxidative damage of skin comprising applying to oxidant damaged skin a topical composition comprising encapsulated resveratrol, oligopeptide-1, niacinamide, and Prunus mume leaf aqueous extract, and optionally one or more of Opuntia tuna fruit extract, malachite extract, adenosine, algae extract, or Opuntia ficus - indica fruit extract, wherein the combination of encapsulated resveratrol, oligopeptide-1, and niacinamide reduces oxidative damage in the skin, and wherein the oligopeptide-1 comprises the sequence of caprooyl-Gly-His-Lys-Lys.

2. The method of claim 1 , wherein further the oligopeptide-1 inhibits tyrosinase, increases production of elastin, stimulates collagen production and/or secretion, and/or inhibits TNF-α; niacinamide inhibits melanogenesis and Prunus mume leaf aqueous extract stimulates collagen production and/or secretion, increases laminin production, and/or increases antioxidant capacity of the composition; and optionally Opuntia tuna fruit extract inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and/or inhibits TNF-α; malachite extract inhibits MMP1, inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and/or increases antioxidant capacity of the composition; algae extract increases skin barrier integrity; and/or Opuntia ficus - indica fruit extract inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and/or inhibits TNF-α.

3. The method of claim 1 , wherein the topical composition comprises:

0.00001 to 0.1% by weight of encapsulated resveratrol, 0.0000001 to 0.01% by weight of oligopeptide-1, 0.001 to 3% by weight of niacinamide, and 0.01 to 3% by weight of Prunus mume leaf aqueous extract: and

optionally one or more of 0.00001 to 0.01% by weight of Opuntia tuna fruit extract, 0.00001 to 0.1% by weight of malachite extract, 0.001 to 1% by weight of adenosine, 0.001 to 1% by weight of algae extract, or 0.001 to 3% by weight of Opuntia ficus - indica fruit extract.

4. The method of claim 1 , wherein the topical composition is applied to the skin daily.

5. The method of claim 2 , wherein:

the oligopeptide-1 inhibits tyrosinase, increases production of elastin, stimulates collagen production and/or secretion, and/or inhibits TNF-α; niacinamide inhibits melanogenesis; and Prunus mume leaf extract stimulates collagen production and/or secretion, increases laminin production, and/or increases antioxidant capacity of the composition, and

optionally wherein Opuntia tuna fruit extract inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and/or inhibits TNF-α; malachite extract inhibits MIMP1, inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and/or increases antioxidant capacity of the composition; algae extract increases skin barrier integrity; and/or Opuntia ficus - indica fruit extract inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and/or inhibits TNF-α.

6. The method of claim 2 , wherein:

the oligopeptide-1 inhibits tyrosinase, increases production of elastin, stimulates collagen production and/or secretion, and inhibits TNF-α; niacinamide inhibits melanogenesis; and Prunus mume leaf extract stimulates collagen production and/or secretion, increases laminin production, and increases antioxidant capacity of the composition; and

optionally wherein Opuntia tuna fruit extract inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and inhibits TNF-α; malachite extract inhibits MIMP1, inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and increases antioxidant capacity of the composition; algae extract increases skin barrier integrity; and/or Opuntia ficus - indica fruit extract inhibits COX-1, inhibits COX-2, inhibits lipoxygenase, and inhibits TNF-α.

7. The method of claim 2 , wherein the topical composition further comprises water, hydroxyacetophenone, and tocopheryl acetate.

8. The method of claim 7 , wherein the topical composition comprises:

0.00001 to 0.1% by weight of encapsulated resveratrol, 0.0000001 to 0.01% by weight of oligopeptide-1, 0.001 to 3% by weight of niacinamide, 0.01 to 3% by weight of Prunus mume leaf aqueous extract, 25 to 98% by weight of water, 0.01 to 3% by weight of hydroxyacetophenone, and 0.001 to 1% by weight of tocopheryl acetate,

and optionally one or more of 0.00001 to 0.01% by weight of Opuntia tuna fruit extract, 0.00001 to 0.1% by weight of malachite extract, 0.001 to 1% by weight of adenosine, 0.001 to 1% by weight of algae extract, or 0.001 to 3% by weight of Opuntia ficus - indica fruit extract.

9. The method of claim 2 , wherein the topical composition further comprises isohexadecane, dimethicone, aluminum starch octenyl succinate, and caprylic/capric triglyceride.

10. The method of claim 9 , wherein the topical composition comprises:

0.00001 to 0.1% by weight of encapsulated resveratrol, 0.0000001 to 0.01% by weight of oligopeptide-1, 0.001 to 3% by weight of niacinamide, 0.01 to 3% by weight of Prunus mume leaf aqueous extract, 0.01 to 15% by weight of isohexadecane, 0.01 to 10% by weight of dimethicone, 1 to 10% by weight of aluminum starch octenyl succinate, and 0.01 to 3% by weight of caprylic/capric triglyceride,

and optionally one or more of 0.00001 to 0.01% by weight of Opuntia tuna fruit extract, 0.00001 to 0.1% by weight of malachite extract, 0.001 to 1% by weight of adenosine, 0.001 to 1% by weight of algae extract, or 0.001 to 3% by weight of Opuntia ficus - indica fruit extract.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 069414/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2017
From: CARLE, TIFFANY; GAN, DAVID; KALAHASTI, GEETHA; FRUSHOUR, MICHAEL S; JACOBY, PATRICIA
To: MARY KAY INC.
Reel/Frame 042488/0961 →